Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.080 |
None |
1.000 |
8 |
|
2011 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.060 |
None |
1.000 |
6 |
|
2011 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.050 |
None |
1.000 |
5 |
|
2011 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.040 |
None |
1.000 |
4 |
|
2011 |
2016 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.040 |
None |
1.000 |
4 |
|
2013 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.030 |
None |
1.000 |
3 |
|
2011 |
2016 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2016 |
Nasopharyngeal carcinoma
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
1553
|
320
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2019 |
Parkinson Disease
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
2078
|
990
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2017 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2016 |
Post-Traumatic Osteoporosis
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
61
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2104
|
309
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Carotid Atherosclerosis
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
219
|
79
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Sarcoma
|
group |
Neoplasms
|
Neoplastic Process
|
853
|
42
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Triple-Negative Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1598
|
96
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Osteoporosis, Age-Related
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
89
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Coronary Artery Dissection, Spontaneous
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Disease or Syndrome
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Laryngeal cleft
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
72
|
4
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Benign Prostatic Hyperplasia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
770
|
91
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Ovarian Serous Adenocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
143
|
65
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Triple Negative Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1674
|
99
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Platelet Component Distribution Width Measurement
|
phenotype |
|
Laboratory Procedure
|
134
|
200
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |